Euro-GASP external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing 2016
An EQA scheme for antimicrobial susceptibility testing of Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This is the second report to be published on the European N. gonorrhoeae EQA and has shown high levels of inter-laboratory comparability in the presence of differing methodologies across 25 countries. Overall concordance increased for most antimicrobials, except for azithromycin where the overall concordance decreased to the lowest level yet recorded.
European Gonococcal Antimicrobial Surveillance Programme: external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing
2 Feb 2017 - This is an external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility established in 2007 as part of the European Surveillance to STIs programme.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2014
31 Aug 2016 - The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC) since 2009.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2013
9 Jul 2015 - During 2013, the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) followed the biannual decentralised and centralised testing model used in previous years, requesting participating laboratories to collect gonococcal isolates during two periods (April/May and October/November).